Sanofi gets CDSCO approval for Qfitlia haemophilia therapy in India
Sanofi Healthcare has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Qfitlia (fitusiran), a therapy to prevent bleeding in haemophilia patients. The approval covers adults and adolescents aged…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.